Public Company News

Angel Yeast Brings Latest Innovative Products and Solutions to FIC 2022

GUANGZHOU, China, Aug. 19, 2022 /PRNewswire/ -- Angel Yeast , (SH600298), a globally listed yeast and yeast extract manufacturer, showcased its latest yeast and yeast extract products, health ingredients, and fermentation ingredients alongside its wide range of innova...

2022-08-19 15:50 3997

Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ

Data results will be available in Q1 2023 GAITHERSBURG, Md. and SUZHOU, China, Aug. 19, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Compa...

2022-08-19 13:31 3443

Goodix Cooperates with Tuya to Pioneer the Smart Tracker Market with a Smart Tag Solution

SHENZHEN, China, Aug. 19, 2022 /PRNewswire/ -- Together with Tuya Smart (NYSE: TUYA, HKEX: 2391), a global IoT development platform service provider, Goodix (603160.SH) has developed a Smart Tag solution that supports Apple's ecology based on the GR551x series Bluetooth Low Energy SoC. Featured ...

2022-08-19 12:00 3407

Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines

TAIZHOU, China, Aug. 19, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Company has completed the subject enrollment and dosing for the comparative Phase II clinical trial between its recombina...

2022-08-19 11:29 3976

9F Inc. Announces Receipt of Minimum Bid Price Notice from Nasdaq

BEIJING, Aug. 18, 2022 /PRNewswire/ -- 9F Inc. (NASDAQ: JFU) ("9F" or the "Company") today announced that it has received a written notification from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") datedAugust 12, 2022, indicating that for the last 30 ...

2022-08-19 04:05 2434

Amorepacific Develops World's First Chip-less Wireless Electronic Skin Enabled by Semiconductors

SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- Amorepacific, a South Korean beauty and cosmetics conglomerate, in collaboration with ProfessorKim Jeehwan at MIT, has developed the world's first chip-less wireless wearable electronic skin (e-skin) that is sweatproof and can continuously monitor ...

2022-08-19 02:00 2814

Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ

Data results will be available in Q1 2023 GAITHERSBURG, Md. and SUZHOU, China, Aug. 18, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Compa...

2022-08-18 23:46 2113

Maoyan Entertainment Announces Interim Results for the First Half of 2022

BEIJING, Aug. 18, 2022 /PRNewswire/ -- Maoyan Entertainment ("Maoyan" or the "Company", 1896.HK), a leading platform providing innovative Internet empowered entertainment services inChina, today announced its audited consolidated results for the six months endedJune 30, 2022. First Half 2022 Fin...

2022-08-18 22:18 4523

JCET Performance Hits Another Record High in 1H 2022, Benefiting From Global Resource Optimization

Q2 2022 Financial Highlights: * Revenue was RMB 7.46 billion, an increase of 4.9% year on year. A record high second quarter in the company's history. * Generated RMB 1.04 billion cash from operations. With net capex investments ofRMB 0.64 billion, free cash flow for the quarter was RMB 0.4 b...

2022-08-18 22:03 4537

Ping An Health posts revenue of RMB2,828 million in the first half of 2022

Gross margin improves to 27.3% Cumulative paying users reaches over 40 million HONG KONG and SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or "Ping An Health"; Stock Code: 1833.HK), announced its 2022 interim results. Since the de...

2022-08-18 21:53 4409

JCET Performance Hits Another Record High in 1H 2022, Benefiting From Global Resource Optimization

Q2 2022 Financial Highlights: * Revenue was RMB 7.46 billion, an increase of 4.9% year on year. A record high second quarter in the company's history. * Generated RMB 1.04 billion cash from operations. With net capex investments ofRMB 0.64 billion, free cash flow for the quarter was RMB 0.4 b...

2022-08-18 21:38 3746

Henlius 2022 H1 Results: Sharpen all-round edges, advance in evolution to Biopharma

SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its 2022 interim results. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched inChina, 1 in ...

2022-08-18 21:35 4455

Adyen advances in-person payments with the launch of in-house designed terminal range

* The company is releasing two new terminals, the NYC1 and the AMS1, after expanding into designing hardware for the first time  * The terminals are affordable and flexible solutions that simplify accepting in-person payments for enterprise and platform businesses AMSTERDAM, Aug. 18, 2022 /PR...

2022-08-18 21:25 5720

Yeahka Limited to Report 2022 Interim Results on Tuesday, August 30, 2022

HONG KONG, Aug. 18, 2022 /PRNewswire/ -- Yeahka Limited ("Yeahka" or the "Company", stock code: 9923.HK), a leading payment-based technology platform in China, today announced that it will report its unaudited financial results for the 6 months endedJune 30, 2022. The Company's management wi...

2022-08-18 21:24 4788

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17

* Nuvaxovid™ is New Zealand's only protein-based COVID-19 vaccine GAITHERSBURG, Md., Aug. 18, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that New...

2022-08-18 21:06 3396

Senmiao Technology Launches Ride-Hailing Platform in Tianjin and Foshan

CHENGDU, China, Aug. 18, 2022 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focusing on the online ride-hailing industry inChina as well as an operator of its own online ride-hailing platform, today announced the launch o...

2022-08-18 21:00 2408

Luokung Affiliate eMapGo Wins 2022 Microsoft Top App Innovation Partner Award

BEIJING, Aug. 18, 2022 /PRNewswire/ -- Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company"), a leading spatial-temporal intelligent big data services company and provider of interactive location-based services ("LBS") in China, today announced that its operating affiliate eMapGo Te...

2022-08-18 21:00 3636

CG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic Adenocarcinoma

ORINDA, Calif. and SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- CG Pharmaceuticals, Inc. announced the first patient dosed with the ivaltinostat and capecitabine combination therapy for the Phase1b/2 pancreatic adenocarcinoma (PDAC) maintenance study. Commencement of treatment for the first...

2022-08-18 21:00 2077

Autoliv, Inc. appoints Gustav Lundgren to Board of Directors and Declares Quarterly Dividend

STOCKHOLM, Aug. 18, 2022 /PRNewswire/ -- The Board of Directors of Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), pursuant to the previously disclosed agreement with Cevian Capital II GP Limited ("Cevian"), today appointedGustav Lundgren to the Board of Directors, replacing Min Liu who resigned.  Th...

2022-08-18 20:50 2668

Case Report of Long Term Complete Response in Hepatocellular Carcinoma to CARsgen's GPC3 CAR T Cells (CT011) Published in Frontiers in Immunology

SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that a case report, titled "Long Term Complete Response of Advanced H...

2022-08-18 20:50 2840